Reduced Expression of Annexin A6 Induces Metabolic Reprogramming That Favors Rapid Fatty Acid Oxidation in Triple-Negative Breast Cancer Cells

por Williams, Stephen D., Sakwe, Amos M.
Publicado 2022

How to be a GREAT mentor

por Davis, Jamaine S., Sakwe, Amos M., Ramesh, Aramandla, Lindsey, Merry L., Woods, Letha
Publicado 2023

Association of calcium sensing receptor polymorphisms at rs1801725 with circulating calcium in breast cancer patients

por Wang, Li, Widatalla, Sarrah E., Whalen, Diva S., Ochieng, Josiah, Sakwe, Amos M.
Publicado 2017

Detachment of Breast Tumor Cells Induces Rapid Secretion of Exosomes Which Subsequently Mediate Cellular Adhesion and Spreading

por Koumangoye, Rainelli B., Sakwe, Amos M., Goodwin, J. Shawn, Patel, Tina, Ochieng, Josiah
Publicado 2011

The Calcium-Sensing Receptor (CaSR) Variants at rs1801725 Increase the Risk of Developing Secondary Malignant Cancers

por Beasley, Heather K, Actkins, Ky’Era, Annika, Faucon, Davis, Lea, Sakwe, Amos M
Publicado 2021

Hypoxia-Inducible Expression of Annexin A6 Enhances the Resistance of Triple-Negative Breast Cancer Cells to EGFR and AR Antagonists

por Williams, Stephen D., Smith, Tunde M., Stewart, LaMonica V., Sakwe, Amos M.
Publicado 2022

Calcium-Sensing Receptor Polymorphisms at rs1801725 Are Associated with Increased Risk of Secondary Malignancies

por Actkins, Ky’Era V., Beasley, Heather K., Faucon, Annika B., Davis, Lea K., Sakwe, Amos M.
Publicado 2021

Reduced annexin A6 expression promotes the degradation of activated epidermal growth factor receptor and sensitizes invasive breast cancer cells to EGFR-targeted tyrosine kinase in...

por Koumangoye, Rainelli B, Nangami, Gladys N, Thompson, Pamela D, Agboto, Vincent K, Ochieng, Josiah, Sakwe, Amos M
Publicado 2013

Lapatinib-induced annexin A6 upregulation as an adaptive response of triple-negative breast cancer cells to EGFR tyrosine kinase inhibitors

por Widatalla, Sarrah E, Korolkova, Olga Y, Whalen, Diva S, Goodwin, J Shawn, Williams, Kevin P, Ochieng, Josiah, Sakwe, Amos M
Publicado 2019

Fetuin‐A (alpha 2HS glycoprotein) modulates growth, motility, invasion, and senescence in high‐grade astrocytomas

por Nangami, Gladys N., Sakwe, Amos M., Izban, Michael G., Rana, Tanu, Lammers, Philip E., Thomas, Portia, Chen, Zhenbang, Ochieng, Josiah
Publicado 2016

Diverse Roles of Annexin A6 in Triple-Negative Breast Cancer Diagnosis, Prognosis and EGFR-Targeted Therapies

por Korolkova, Olga Y., Widatalla, Sarrah E., Williams, Stephen D., Whalen, Diva S., Beasley, Heather K., Ochieng, Josiah, Grewal, Thomas, Sakwe, Amos M.
Publicado 2020

The rapid endocytic uptake of fetuin‐A by adherent tumor cells is mediated by Toll‐like receptor 4 (TLR4)

por Thomas, Portia L., Nangami, Gladys, Rana, Tanu, Evans, Adam, Williams, Stephen D., Crowell, Dylan, Shanker, Anil, Sakwe, Amos M., Ochieng, Josiah
Publicado 2020

Fetuin-A Promotes 3-Dimensional Growth in LNCaP Prostate Cancer Cells by Sequestering Extracellular Vesicles to Their Surfaces to Act as Signaling Platforms

por Ochieng, Josiah, Korolkova, Olga Y., Li, Guoliang, Jin, Renjie, Chen, Zhenbang, Matusik, Robert J., Adunyah, Samuel, Sakwe, Amos M., Ogunkua, Olugbemiga
Publicado 2022

Identification of MAGEC2/CT10 as a High Calcium-Inducible Gene in Triple-Negative Breast Cancer

por Beasley, Heather K., Widatalla, Sarrah E., Whalen, Diva S., Williams, Stephen D., Korolkova, Olga Y., Namba, Clementine, Pratap, Siddharth, Ochieng, Josiah, Sakwe, Amos M.
Publicado 2022

Implication of calcium activated RasGRF2 in Annexin A6-mediated breast tumor cell growth and motility

por Whalen, Diva S., Widatalla, Sarrah E., Korolkova, Olga Y., Nangami, Gladys S., Beasley, Heather K., Williams, Stephen D., Virgous, Carlos, Lehmann, Brian D., Ochieng, Josiah, Sakwe, Amos M.
Publicado 2019

Reciprocal expression of Annexin A6 and RasGRF2 discriminates rapidly growing from invasive triple negative breast cancer subsets

por Korolkova, Olga Y., Widatalla, Sarrah E., Whalen, Diva S., Nangami, Gladys N., Abimbola, Adeniyi, Williams, Stephen D., Beasley, Heather K., Reisenbichler, Emily, Washington, Mary Kay, Ochieng, Josiah, Mayer, Ingrid A., Lehmann, Brian D., Sakwe, Amos M.
Publicado 2020

Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease

por Williams, Amanda D., Korolkova, Olga Y., Sakwe, Amos M., Geiger, Timothy M., James, Samuel D., Muldoon, Roberta L., Herline, Alan J., Goodwin, J. Shawn, Izban, Michael G., Washington, Mary K., Smoot, Duane T., Ballard, Billy R., Gazouli, Maria, M'Koma, Amosy E.
Publicado 2017

Correction: Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease

por Williams, Amanda D., Korolkova, Olga Y., Sakwe, Amos M., Geiger, Timothy M., James, Samuel D., Muldoon, Roberta L., Herline, Alan J., Goodwin, J. Shawn, Izban, Michael G., Washington, Mary K., Smoot, Duane T., Ballard, Billy R., Gazouli, Maria, M’Koma, Amosy E.
Publicado 2017

Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn’s colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammat...

por Rana, Tanu, Korolkova, Olga Y., Rachakonda, Girish, Williams, Amanda D., Hawkins, Alexander T., James, Samuel D., Sakwe, Amos M., Hui, Nian, Wang, Li, Yu, Chang, Goodwin, Jeffrey S., Izban, Michael G., Offodile, Regina S., Washington, Mary K., Ballard, Billy R., Smoot, Duane T., Shi, Xuan-Zheng, Forbes, Digna S., Shanker, Anil, M’Koma, Amosy E.
Publicado 2021